Kestra Medical Technologies, Ltd. Common Stock KMTS Cash Flow Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| -$143.89M-9.4% | -$131.48M-10.2% | -$119.32M-4.8% | -$113.81M-32.0% | -$86.23M+2.0% | ||
| $8.22M+1.2% | $8.13M+6.6% | $7.62M-4.4% | $7.97M-11.7% | $9.02M-10.0% | ||
| $45.65M+26.8% | $36M+26.5% | $28.47M+17.3% | $24.27M+942% | $2.33M+3.9% | ||
| —— | —— | —— | $64K+25.5% | $51K+34.2% | ||
| $1.78M+20.3% | $1.48M-11.6% | $1.67M+19.2% | $1.4M+18.3% | $1.18M+1.5% | ||
| -$1.94M+6.5% | -$2.07M+2.1% | -$2.12M-1.2% | -$2.09M-82.2% | -$1.15M-3.1% | ||
| $7.11M-8.8% | $7.79M+1.6% | $7.66M-12.7% | $8.78M+4.0% | $8.44M+47.6% | ||
| —— | —— | —— | —— | $5.5M+65.4% | ||
| $6.08M+81.4% | $3.35M-7.4% | $3.62M-21.7% | $4.62M+63.6% | $2.82M+43.2% | ||
| -$40K0.0% | -$40K0.0% | -$40K0.0% | -$40K-45.5% | -$27.5K-83.3% | ||
| —— | —— | —— | —— | —— | ||
| -$399K-496% | -$67K-132% | $210K-43.2% | $370K+234% | $110.75K+200% | ||
| -$87.04M-0.4% | -$86.67M-0.3% | -$86.38M-11.3% | -$77.61M-8.4% | -$71.61M+0.1% | ||
| $32.62M+21.3% | $26.88M+11.7% | $24.07M+4.9% | $22.94M+23.3% | $18.6M+5.7% | ||
| -$37.98M-38.1% | -$27.51M-12.2% | -$24.51M-5.1% | -$23.31M-22.9% | -$18.96M-7.9% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $215.79M— | —— | ||
| —— | —— | —— | —— | —— | ||
| $361.98M— | —— | —— | —— | —— | ||
| $236.97M— | —— | —— | —— | —— | ||
| —— | $5.25M+3.8% | $5.05M+4.2% | $4.85M+6.9% | $4.54M+6.3% | ||
| —— | —— | —— | —— | —— | ||
| $1.78M+20.3% | $1.48M-11.6% | $1.67M+19.2% | $1.4M+18.3% | $1.18M+1.5% | ||
| $6.08M+81.4% | $3.35M-7.4% | $3.62M-21.7% | $4.62M+63.6% | $2.82M+43.2% | ||
| —— | -$2.92M+11.6% | -$3.3M+4.0% | -$3.44M-10.4% | -$3.12M-82.8% | ||
| -$399K-496% | -$67K-132% | $210K-43.2% | $370K+234% | $110.75K+200% | ||
| —— | $846K— | —— | —— | —— | ||
| $359K+11.5% | $322K-0.9% | $325K-21.9% | $416K-18.8% | $512.25K-15.5% | ||
| —— | —— | —— | $855K-12.5% | $977.5K-3.8% | ||
| $2.33M-16.0% | $2.77M+6.5% | $2.6M-3.5% | $2.69M+34.2% | $2.01M+51.7% | ||
| —— | —— | —— | —— | —— | ||
| $555K-30.3% | $796K+7.9% | $738K+12.7% | $655K-6.3% | $699K+105% | ||
| $197K+13.9% | $173K-41.8% | $297K+4.9% | $283K-17.1% | $341.25K-7.6% | ||
| —— | —— | —— | $1.65M-10.5% | $1.85M-7.5% | ||
| —— | —— | —— | $3.52M— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $2.37M— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $1.88M— | —— | ||
| —— | —— | —— | $280.51M— | —— | ||
| —— | —— | -$923K-135% | $2.65M— | —— | ||
| -$399K-496% | -$67K-132% | $210K-43.2% | $370K+234% | $110.75K+200% | ||
| —— | —— | —— | $5.45M— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$119.66M-5.4% | -$113.55M-2.8% | -$110.45M-9.9% | -$100.54M-11.5% | -$90.21M-1.1% | ||
| -$119.66M-5.4% | -$113.55M-2.8% | -$110.45M-9.9% | -$100.54M-11.5% | -$90.21M-1.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Kestra Medical Technologies, Ltd. Common Stock generate?
- Kestra Medical Technologies, Ltd. Common Stock (KMTS) generated -$87.0M in operating cash flow over the trailing twelve months.
- What is Kestra Medical Technologies, Ltd. Common Stock's free cash flow?
- After $32.6M of capital expenditures, Kestra Medical Technologies, Ltd. Common Stock's free cash flow was -$119.7M over the trailing twelve months, down 32.6% year over year.
- Where does Kestra Medical Technologies, Ltd. Common Stock's cash flow data come from?
- Every line is extracted from Kestra Medical Technologies, Ltd. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
